Avda. de la Plata, 20
46013 Valencia
Teléfono: 963355110
Fax: 963348702
 
 
Hepatología

Portales de hepatología

Resúmenes de Congresos

63rd Annual Meeting of the American Association for the Study of Liver Diseases
Boston, 9-13 noviembre 2012 47th Annual Meeting of the European Association for the Study of the Liver
Barcelona, 18-22 abril 2012 XXXVII Congreso Anual de la Fundación/Asociación Española para el Estudio del Hígado
Madrid, 15-17 febrero 2012

Guías de práctica clínica

 
The diagnosis and management of non-alcoholic fatty liver disease (AASLD, ACG & AGA).
Hepatology 2012;55:2005-2023

The management of acute liver failure: Update 2011 (AASLD Position Paper).
Hepatology 2012;55:965-967

An update on treatment of genotype 1 chronic hepatitis C virus infection.
Hepatology 2011;54:1433-1444

Diagnosis and management of hemochromatosis.
Hepatology 2011;54:328-343

Management of hepatocellular carcinoma: An update.
Hepatology 2011;53:1020-1022

Diagnosis and management of autoimmune hepatitis.
Hepatology 2010;51:2193-2213

Diagnosis and management of primary sclerosing cholangitis.
Hepatology 2010;51:660-678

Alcoholic liver disease.
Hepatology 2010;51:307-328

The role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension: Update 2009.
Hepatology 2010;51:306

Chronic hepatitis B: Update 2009.
Hepatology 2009;50:661-662

Primary Biliary Cirrhosis.
Hepatology 2009;450:291-308

Management of adult patients with ascites due to cirrhosis: An update.
Hepatology 2009;49:2087-2107

Vascular disorders of the liver.
Hepatology 2009;49:1729-1764

Diagnosis, management, and treatment of hepatitis C: An update.
Hepatology 2009;49:1335-1374

Liver biopsy (AASLD Position Paper).
Hepatology 2009;49:1017-1044

Diagnosis and treatment of Wilson disease: an update.
Hepatology 2008;47:2089-2111

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.
Hepatology 2007;46:922-938

Evaluation of the patient for liver transplantation.
Hepatology 2005;41:1407-1432

Laboratory guidelines for screening, diagnosis and monitoring of hepatic injury.
Clinical Chemistry 2000;46:2027-2049 y Clinical Chemistry 2000;46:2050-2068

Management of alcoholic liver disease.
Journal of Hepatology 2012;57:399-420

Management of chronic hepatitis B virus infection.
Journal of Hepatology 2012;57:167-185

Management of hepatocellular carcinoma (EASL-EORTC).
Journal of Hepatology 2012;56:908-943

Wilson's disease.
Journal of Hepatology 2012;56:671-685

Management of hepatitis C virus infection.
Journal of Hepatology 2011;55:245-264

Management of ascitis, spontaneous bacterial peritonitis and hepatorrenal syndrome in cirrhosis.
Journal of Hepatology 2010;53:397-417

HFE hemochromatosis.
Journal of Hepatology 2010;53:3-22

Management of cholestatic liver diseases.
Journal of Hepatology 2009;51:237-267

AGA Medical Position Statement - Management of hepatitis C.
Gastroenterology 2006;130:225-230

AGA Technical Review - Management of hepatitis C.
Gastroenterology 2006;130:231-264

AGA Medical Position Statement - Osteoporosis in hepatic disorders.
Gastroenterology 2003;125:937-940

AGA Technical Review - Osteoporosis in hepatic disorders.
Gastroenterology 2003;125:941-966

AGA Medical Position Statement - Nonalcoholic fatty liver disease.
Gastroenterology 2002;123:1702-1704

AGA Technical Review - Nonalcoholic fatty liver disease.
Gastroenterology 2002;123:1705-1725

AGA Medical Position Statement - Evaluation of liver chemistry tests.
Gastroenterology 2002;123:1364-1366

AGA Technical ReviewEvaluation of liver chemistry tests.
Gastroenterology 2002;123:1367-1384

Calculadoras

Pronóstico de la cirrosis hepática
Miscelánea
Enfermedades colestásicas crónicas
Hepatopatía alcohólica
Función renal
(*) Alojadas originalmente en Timely Topics in Medicine - Hepatología

Conferencias de consenso

Otros enlaces

EASL Meeting Reports

AASLD Single Topic Conferences

Recomendaciones de profilaxis

  • Hepatitis C Virus Testing of Persons Born During 1945 to 1965: Recommendations From the Centers for Disease Control and Prevention.
    MMWR 2012;61(RR-4):1-32
  • Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students.
    MMWR 2012;61(RR-3):1-12
  • Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
    MMWR 2008;57(RR08):1-20
  • A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    MMWR 2006;55(RR-16)
  • A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part I: immunization of infants, children, and adolescents.
    MMWR 2005;54(RR-16)
  • Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force.
    Annals of Internal Medicine 2004;140:465-479
  • Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus.
    MMWR 2003;52(RR-3):1-13
  • Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    MMWR 2001;50(RR-11)
  • Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR 1999;48(RR-12)
  • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.
    MMWR 1998;47(RR-19)

Aplicaciones para iPod/iPad/iPhone

 
 
 

Boceprevir - Telaprevir

  Guías práctica clínica
Calculadoras
Conferencias consenso
Otros enlaces
Aplicaciones iPhone
Boceprevir - Telaprevir
 

 
 
| Inicio | Historia | Junta Directiva | Estatutos | Reglamento | Socios | Grupos de trabajo | Actividades | Enlaces |